Index/Topics/Phosphatidylserine Trials

Phosphatidylserine Trials

Phosphatidylserine trials typically use about 100–300 mg.

Fact-Checks

5 results

Jan 18, 2026

What safety signals and drug interactions have been reported for Ginkgo, phosphatidylserine, and Bacopa in clinical trials?

Clinical trials and systematic reviews report generally mild safety signals for Ginkgo biloba, phosphatidylserine (PS), and Bacopa monnieri — principally gastrointestinal complaints, headache, and occ...

Feb 1, 2026

Which clinical trials support individual ingredients in Neuro Defender at the doses used in human studies?

’s ingredients largely mirror compounds that have been tested in human clinical trials—examples cited in the reporting include , , , , /Alpha-GPC, Rhodiola, and —each of which appears in trials at cha...

Jan 31, 2026

What clinical evidence supports the efficacy of Brain Defender ingredients?

Clinical studies support cognitive effects for several individual ingredients listed on —most notably , , and —yet the product’s proprietary 1,200 mg blend obscures whether those ingredients are prese...

Jan 27, 2026

Which clinical trials have tested combinations of phosphatidylserine, bacopa and lion's mane for memory in older adults?

No randomized clinical trial was identified in the provided reporting that tests a three-way combination of phosphatidylserine (PS), Bacopa monnieri (bacopa) and Hericium erinaceus (lion’s mane) speci...

Jan 5, 2026

Which ingredients are listed on MemoBlast product labels and what does peer‑reviewed research say about each one?

MemoBlast’s label, as represented across official product pages and third‑party reviews, lists a mix of botanicals, amino acids, polyphenols and other extracts — names frequently invoked in cognitive‑...